# Hematology * **Definition:** The branch of medicine concerned with the study of blood, blood disorders, and the diagnosis and treatment of blood-related diseases. * **Taxonomy:** Specialties / Hematology ## News * Selected news on the topic of **Hematology**, for healthcare technology leaders * 5.5K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 4/30/2025 | [**Genocury Biotech Annouces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy**](https://www.prnewswire.com/news-releases/genocury-biotech-annouces-groundbreaking-advance-in-relapsedrefractory-dlbcl-through-pioneering-in-vivo-cd19-car-t-therapy-302442371.html) | [[PR Newswire]] | | 4/23/2025 | [**Point of Care Hematology Diagnostics Market to Reach $3.0 Bn by 2027 in the short run and $3.6 Bn by 2030 Globally, at 5.8AGR: Allied Market Research**](https://www.globenewswire.com/news-release/2025/04/23/3066132/0/en/Point-of-Care-Hematology-Diagnostics-Market-to-Reach-3-0-Bn-by-2027-in-the-short-run-and-3-6-Bn-by-2030-Globally-at-5-8-CAGR-Allied-Market-Research.html) | [[Globe Newswire]] | | 4/22/2025 | [**Veterinary Poc Hematology Diagnostics Market to Reach $1.7 Bn by 2027 in the short run ...**](https://www.prnewswire.com/news-releases/veterinary-poc-hematology-diagnostics-market-to-reach-1-7-bn-by-2027-in-the-short-run-and-2-3-bn-by-2030-globally-at-9-3-cagr-allied-market-research-302434392.html) | [[PR Newswire]] | | 2/22/2025 | [**The Future of Digital Health: Key Trends and Opportunities in 2025 - by Kartheek Rao**](https://medium.com/@kartheekraom/the-future-of-digital-health-key-trends-and-opportunities-in-2025-64001a178563) | [[Medium]] | | 2/18/2025 | [**APSHO Issues Position Statement Affirming Commitment to Inclusive Hematology/Oncology Care**](https://www.prweb.com/releases/apsho-issues-position-statement-affirming-commitment-to-inclusive-hematologyoncology-care-302377800.html) | [[PRWeb]] | | 2/5/2025 | [**32 Physicians and Surgeons from Virginia Cancer Specialists Named as NorthernVirginia ...**](https://www.prnewswire.com/news-releases/32-physicians-and-surgeons-from-virginia-cancer-specialists-named-as-northernvirginia-magazines-2025-top-doctors-302367661.html) | [[PR Newswire]] | | 2/5/2025 | [**32 Physicians and Surgeons from Virginia Cancer Specialists Named as NorthernVirginia ...**](https://finance.yahoo.com/news/32-physicians-surgeons-virginia-cancer-120400734.html) | [[Yahoo Finance]] | | 2/5/2025 | [**32 Physicians and Surgeons from Virginia Cancer Specialists Named as NorthernVirginia ...**](https://www.morningstar.com/news/pr-newswire/20250205ne11203/32-physicians-and-surgeons-from-virginia-cancer-specialists-named-as-northernvirginia-magazines-2025-top-doctors) | [[Morningstar]] | | 1/23/2025 | [**Florida Oncology and Hematology and American Oncology Network Welcome Dr. Michele Ramirez**](https://www.morningstar.com/news/globe-newswire/9336275/florida-oncology-and-hematology-and-american-oncology-network-welcome-dr-michele-ramirez) | [[Morningstar]] | | 1/23/2025 | [**Florida Oncology and Hematology and American Oncology Network Welcome Dr. Michele Ramirez**](https://finance.yahoo.com/news/florida-oncology-hematology-american-oncology-130000072.html) | [[Yahoo Finance]] | | 1/21/2025 | [**Florida Oncology and Hematology Relocates Fort Myers Clinic - Morningstar**](https://www.morningstar.com/news/globe-newswire/9334807/florida-oncology-and-hematology-relocates-fort-myers-clinic) | [[Morningstar]] | | 12/30/2024 | [**Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting**](https://www.globenewswire.com/news-release/2024/12/30/3002628/0/en/Hematology-Oncology-of-Indiana-Physician-Research-Presented-at-66th-ASH-Annual-Meeting.html) | [[Globe Newswire]] | | 12/30/2024 | [**Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting**](https://finance.yahoo.com/news/hematology-oncology-indiana-physician-research-130000304.html) | [[Yahoo Finance]] | | 12/12/2024 | [**Global Hematology Market to Exhibit Growth at a CAGR of ~8y 2030 - DelveInsight**](https://finance.yahoo.com/news/global-hematology-market-exhibit-growth-223100751.html) | [[Yahoo Finance]] | | 12/12/2024 | [**Global Hematology Market to Exhibit Growth at a CAGR of ~8y 2030 - DelveInsight**](https://www.prnewswire.com/news-releases/global-hematology-market-to-exhibit-growth-at-a-cagr-of-8-by-2030--delveinsight-302329737.html) | [[PR Newswire]] | | 12/2/2024 | [**SonoThera Presents New Data at the American Society of Hematology (ASH) Annual Meeting Demonstrating the Potential of Targeted, Ultrasound-Mediated Gene Delivery to Liver**](http://www.businesswire.com/news/home/20241202866035/en/SonoThera-Presents-New-Data-at-the-American-Society-of-Hematology-ASH-Annual-Meeting-Demonstrating-the-Potential-of-Targeted-Ultrasound-Mediated-Gene-Delivery-to-Liver/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/26/2024 | [**Blood Buddies: Can Mentorship Revive Classical Hematology?**](https://www.medscape.com/viewarticle/blood-buddies-can-mentorship-revive-classical-hematology-2024a1000ljs) | [[Medscape]] | | 11/1/2024 | [**Rare Hematology Market to Grow by USD 4.58 Billion (2024-2028) as Strategic Portfolio ...**](https://www.prnewswire.com/news-releases/rare-hematology-market-to-grow-by-usd-4-58-billion-2024-2028-as-strategic-portfolio-enhancements-drive-revenue-ais-impact-on-market-trends-report---technavio-302291133.html) | [[PR Newswire]] | | 9/23/2024 | [**VetsinTech Announces Finalists in Tech Startup Pitch Competition 2024 - Yahoo Finance**](https://finance.yahoo.com/news/vetsintech-announces-finalists-tech-startup-124700858.html) | [[Yahoo Finance]] | | 9/23/2024 | [**Hematology Diagnostics Market Focused Insights 2024-2029, with Coverage of Industry Leaders Abbott, Sysmex, Danaher, Boule Diagnostics, HORIBA, Siemens Healthineers, Nihon Kohden and Diatron - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20240923436637/en/Hematology-Diagnostics-Market-Focused-Insights-2024-2029-with-Coverage-of-Industry-Leaders-Abbott-Sysmex-Danaher-Boule-Diagnostics-HORIBA-Siemens-Healthineers-Nihon-Kohden-and-Diatron---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/2/2024 | [**Global Hematology Analyzers and Reagents Market to Hit $8 Billion by 2030: Technological Advances and Rising Blood Disorders Drive Growth**](http://prsync.com/market-study-report/global-hematology-analyzers-and-reagents-market-to-hit--billion-by--technological-advances-and-rising-blood-disorders-drive-grow-4264813/) | [[PRSync]] | | 8/13/2024 | [**Immunohematology Market to Reach $3.0 Billion, Globally, by 2033 at 4.6% CAGR: Allied Market Research**](https://www.globenewswire.com/news-release/2024/08/13/2929472/0/en/Immunohematology-Market-to-Reach-3-0-Billion-Globally-by-2033-at-4-6-CAGR-Allied-Market-Research.html) | [[Globe Newswire]] | | 8/1/2024 | [**Study finds external mentorship key in encouraging trainees to pursue classical hematology**](https://medicalxpress.com/news/2024-08-external-mentorship-key-trainees-pursue.html) | [[MedicalXpress]] | | 7/15/2024 | [**EHA: Bridging Breakthroughs in Hematology**](https://www.prnewswire.com/news-releases/eha-bridging-breakthroughs-in-hematology-302196840.html) | [[PR Newswire]] | | 7/15/2024 | [**EHA: Bridging Breakthroughs in Hematology**](https://www.prnewswire.com/news-releases/eha-bridging-breakthroughs-in-hematology-302196838.html) | [[PR Newswire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Hematology/Oncology Pharmacy Association (HOPA)**: An organization supporting pharmacy professionals in hematology and oncology, providing education and advocacy. - **Danaher**: A global science and technology innovator that provides a range of diagnostic solutions, including hematology. - **European Hematology Association (EHA)**: An organization committed to advancing research and collaboration in hematology, participating in the ASH Annual Meeting. - **Siemens Healthineers**: A healthcare company that offers a variety of diagnostic imaging and laboratory diagnostics, including hematology solutions. - **Florida Oncology and Hematology (FOH)**: A practice dedicated to providing innovative cancer treatment and patient-centered care. - **Advanced Practitioner Society for Hematology and Oncology (APSHO)**: An organization focused on education and advocacy for advanced practitioners in hematology and oncology. - **bluebird bio**: A biotechnology company focused on gene therapies for hematologic diseases, including sickle cell disease and beta-thalassemia. - **Sobi**: A biopharmaceutical company focusing on hematology, reporting significant growth in its hematology segment, particularly with its product Doptelet. - **Johnson & Johnson**: A major healthcare company presenting data on blood cancer therapies, including multiple myeloma and B-cell malignancies. - **ConcertAI and NeoGenomics**: Collaborative partners launching CTO-H, a software-as-a-service solution for hematological disease research and clinical trial optimization. - **Dr. Alexis A. Thompson**: Chief of the Division of Hematology at Children's Hospital of Philadelphia, recognized for her contributions to sickle cell disease treatment and research. - **Abbott**: A significant contributor to the hematology diagnostics market, emphasizing innovation and product development. - **Ascentage Pharma**: A biopharmaceutical company specializing in innovative treatments for hematologic malignancies, including the investigational drug olverembatinib. - **Beam Therapeutics**: A biotechnology company focused on gene editing treatments for sickle cell disease and other hematological conditions. - **ReAlta Life Sciences, Inc.**: A biotechnology company focused on developing therapies for hematologic diseases, recently announced positive preclinical data for its lead asset RLS-0071. - **ConcertAI**: A leader in predictive AI and real-world data solutions, partnered with NeoGenomics to launch CTO-H, a software-as-a-service solution for hematological diseases. - **Bio-Techne Corporation**: A global life sciences company that develops diagnostic tools for hematology, recently achieving Class B Certification under EU regulations. ### Partnerships and Collaborations - **American Society of Hematology**: Developed a mentorship program to enhance career development and networking opportunities for hematology trainees. - **Bio-Techne and Wilson Wolf**: Partnering to create tailored products for high throughput manufacturing in hematology. - **ConcertAI and NeoGenomics**: Launching CTO-H, a comprehensive dataset for hematological diseases to enhance clinical trial design and operational efficiencies. - **Lowcountry Oncology Associates and OneOncology**: Partnering to improve cancer service delivery in Charleston, South Carolina, expanding hematology services. - **EHA Congress networking opportunities**: Facilitates mentorship between early-career and experienced hematologists. - **Dr. Yongke Zhang and Brazilian Onco-Hematology Physicians**: Discussed potential collaborations in cancer therapy development at the Hematology Center in Brazil. - **Children's Hospital of Philadelphia and University of Pennsylvania**: Authored research on the role of inflammatory memory in hematopoietic stem cells in the context of AML. - **Children's Hospital Los Angeles (CHLA)**: Participating in the ASH Annual Meeting to present research on pediatric blood cancers, showcasing advancements in treatment. - **EHA and ASH**: Collaborating for a joint symposium focusing on myelodysplastic syndromes at the ASH Annual Meeting. - **Florida Oncology and Hematology and American Oncology Network (AON)**: FOH partners with AON to expand its network and improve patient outcomes through value-based care. - **ONCare Alliance and East Texas Hematology Oncology**: Partnership to support independent oncology practices with access to advanced clinical trials and operational support. - **Collaboration between community centers and academic medical centers**: Essential for improving patient access to complex cellular therapies. - **CareDx and TC BioPharm**: A strategic partnership to conduct pharmacokinetic analysis in the ACHIEVE clinical trial for AML and MDS. - **Fort Wayne Medical Oncology and Hematology (FWMOH) and AON**: FWMOH joined AON to enhance patient-focused services and expand its cancer care capabilities. - **Inova Health System**: Collaborates with various institutions to personalize cancer treatment through extensive data analysis. - **Caris Life Sciences**: Appointed Dr. James Hamrick to lead its Precision Oncology Alliance, a network aimed at advancing precision medicine and biomarker-driven research. - **Integrated Oncology Network (ION) and California Cancer Associates for Research and Excellence (cCARE)**: Opened a new office in Chula Vista, California, to enhance cancer care accessibility, offering hematology services. - **Allied Against Cancer**: A collaboration involving multiple organizations to improve cancer care in Sub-Saharan Africa, focusing on evidence-based strategies. ### Innovations, Trends, and Initiatives - **Molecular Diagnostics and Targeted Therapies**: Recent breakthroughs in hematology emphasize the importance of molecular diagnostics and targeted therapies in managing blood disorders. - **Hematology Diagnostics Market Growth**: Projected to grow from USD 3.87 billion in 2023 to USD 5.12 billion by 2029, driven by technological advancements and increasing demand. - **Health Equity Initiative**: The American Society of Hematology launched 'Treating Fairly' to address inequities in hematology care, focusing on quality improvement. - **Hematology Analyzers Market Growth**: The global hematology analyzers and reagents market is projected to grow significantly, driven by technological advancements and increasing awareness of blood disorders. - **AI in Hematology**: Integration of AI technologies in hematology analyzers is enhancing diagnostic accuracy and efficiency. - **Hematology Analyzers and Reagents Market**: Projected to grow from USD 6.6 billion in 2024 to USD 8.8 billion by 2029, driven by technological advancements and increasing blood disorder incidences. - **Point of Care Diagnostics**: The hematology diagnostics segment is evolving with rapid diagnostic tests and advanced technologies to improve patient outcomes. - **AstraZeneca's Hematology Pipeline**: Showcasing advancements in cell therapies and T-cell engagers at the 66th American Society of Hematology Annual Meeting. - **EHA Congress 2024**: Focuses on advancements in hematology and oncology, including gene therapy accessibility and minimal residual disease in multiple myeloma. - **Point-of-Care (POC) Hematology Testing**: Increasing demand for POC testing is transforming diagnostic procedures, allowing tests to be conducted outside traditional laboratory settings. - **FDA Approvals**: Recent approvals for treatments targeting hemophilia, sickle cell disease, and thalassemia are driving growth in the rare hematology market. - **EHA2024 Congress**: Achieved record attendance, showcasing the growing interest in hematology and the establishment of a global network of professionals. - **Life Cycle Assessment (LCA) methodology**: Advocated for reducing greenhouse gas emissions in hematology care. - **Point-of-Care Testing**: Growing demand for POC hematology testing is transforming patient care by enabling tests outside traditional laboratory settings. - **ASH Minority Recruitment Initiative**: A program aimed at increasing diversity in hematology by recruiting underrepresented physicians through mentorship and research opportunities. - **KFSHRC Advanced Hematology Diagnostics Laboratory**: Inaugurated the first of its kind in the MENA region, featuring AI-driven image analysis systems for enhanced diagnostics. - **Surrogate Endpoints in Clinical Trials**: A recent paper guiding clinicians on assessing surrogate endpoints in hematologic malignancies, emphasizing their prognostic value. - **Real-World Data Utilization**: Flatiron Health is leveraging real-world data to enhance understanding of treatment strategies for hematologic malignancies. - **Cell and Gene Therapy Market Growth**: Driven by advancements in technologies such as oligonucleotides and viral transfection, focusing on hematology and oncology. - **Fidanacogene elaparvovec**: A gene therapy for hemophilia B that significantly reduces bleeding episodes, showcasing advancements in hematology treatments. ### Challenges and Concerns - **Shortage of Hematologists**: There is a significant shortage of classical hematologists, leading to long wait times for patients requiring treatment. - **Workforce Shortage**: A looming shortage in classical hematology, with only 5% of fellows intending to pursue this subspecialty. - **Physician Shortage**: The ongoing shortage of healthcare providers, particularly in rural and underserved communities, impacting access to hematology services. - **Healthcare Disparities**: Despite advancements, disparities in access to hematology care persist, necessitating initiatives like 'Treating Fairly' to improve equity. - **Regulatory Approval Challenges**: Biotechnology and pharmaceutical companies face hurdles in obtaining regulatory approvals for new hematology treatments. - **Access to Treatments**: Despite advancements, access to gene therapies and treatments for hematologic diseases remains a challenge due to donor shortages and reimbursement issues. - **Patient Recruitment for Trials**: Challenges in patient recruitment for clinical trials in hematology due to complexities in defining patient populations. - **Environmental impact of hematology research**: Need for sustainable practices to reduce the carbon footprint of healthcare processes. - **Oncology Workforce Shortage**: The national shortage of oncologists is increasing the importance of integrating hematology/oncology pharmacists into care teams. - **High Costs and Accessibility**: Challenges in the hematology market include high costs and accessibility issues in low-resource settings. - **Financial Pressures**: Mental health challenges and financial pressures significantly impact patient care and treatment timelines in hematology. - **Access to Care**: Systemic barriers delaying allogeneic hematopoietic cell transplantation for AML patients, with only 42% referred for HLA typing despite eligibility. - **High Costs and Reimbursement Issues**: The immunohematology market faces challenges such as high maintenance costs and low reimbursement rates for blood components. - **Accessibility of gene therapy**: Concerns regarding the availability of innovative treatments for hemophilia patients. - **Infection prevention in CAR T-cell therapy**: Infections are a leading cause of nonrelapse mortality, highlighting the need for improved management strategies. - **Communication of Cancer Diagnoses**: Clinicians face emotional challenges in delivering bad news to patients, highlighting the need for effective communication strategies. - **High Therapy Costs**: Challenges in CAR T-cell therapy market due to high costs and adverse effects, impacting patient access to treatments. - **Infection Risks in MCL Patients**: Patients with mantle cell lymphoma face significantly increased risks of infections, necessitating careful monitoring and management. ## Related Topics [[Hematopathology]]; [[Pediatric Hematology]]